Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomic Testing in Lung Cancer: Past, Present, and Future.

Journal of the National Comprehensive Cancer Network : JNCCN - 1 Mar 2018

Mascaux Céline, Tsao Ming-Sound, Hirsch Fred R

Abstract excerpt

Precision medicine commonly refers to the selection of the most effective cancer treatments based on the presence of specific biomarkers (eg, genomic abnormalities) in a patient's tumor. Therefore, genomic testing is used to identify patients whose tumors harbor the vulnerability that is sensitive to corresponding targeted therapies. This approach allows for the selection of patients who have the greatest chance...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Genetic Testing
Share to Genomics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lung Neoplasms

Share to Molecular Targeted Therapy

Share to Mutation

Share to Neoplasm Staging

Share to Prognosis

Source

Identifiers

PMID: 29523671
DOI: 10.6004/jnccn.2017.7019

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic Testing in Lung Cancer: Past, Present, and Future.PMID 29523671Read ↗

Lung Cancer GenomicsSemantic proximity Read ↗

Genetic Blueprints in Lung Cancer: Foundations for Targeted TherapiesSemantic proximity Read ↗

Recent Advances in Personalized Lung Cancer MedicineSemantic proximity Read ↗

The Genetic Analysis and Clinical Therapy in Lung Cancer: Current Advances and Future DirectionsSemantic proximity Read ↗

Molecular Testing in Lung Cancer: Recommendations and Update.Semantic proximity Read ↗

Recent advances in lung cancer genomics: Application in targeted therapy.Semantic proximity Read ↗

Lung cancer biomarkers, targeted therapies and clinical assays.Semantic proximity Read ↗

Precision Oncology: Who, How, What, When, and When Not?Semantic proximity Read ↗

The evolving paradigm of precision medicine in lung cancer.Semantic proximity Read ↗

How clinically useful is comprehensive genomic profiling for patients with non-small cell lung cancer? A systematic review.Semantic proximity Read ↗

Present and future molecular testing of lung carcinoma.Semantic proximity Read ↗

Harnessing the potential of genomic characterization of mutational profiles to improve early diagnosis of lung cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.